
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.09 | 1.09 | 0.00 |
Shares | 96.94 | 96.94 | 0.00 |
Other | 1.97 | 1.97 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.88 | 18.98 |
Price to Book | 5.44 | 4.34 |
Price to Sales | 6.14 | 2.38 |
Price to Cash Flow | 14.85 | 15.52 |
Dividend Yield | 1.25 | 1.18 |
5 Years Earnings Growth | 3.65 | 10.53 |
Number of long holdings: 83
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AbbVie | US00287Y1091 | 19.07 | 210.40 | +1.19% | |
Gilead | US3755581036 | 8.17 | 112.97 | +0.36% | |
Alnylam | US02043Q1076 | 7.67 | 446.51 | -1.29% | |
Ascendis Pharma AS | US04351P1012 | 5.43 | 194.27 | +0.19% | |
argenx ADR | US04016X1019 | 4.67 | 712.20 | +1.15% | |
Amgen | US0311621009 | 4.62 | 287.71 | +0.74% | |
Nuvalent Inc Class A | - | 2.41 | - | - | |
Insmed | US4576693075 | 2.29 | 136.10 | +0.84% | |
Soleno Therapeutics | US8342033094 | 1.97 | 67.6700 | -1.08% | |
Viridian Therapeutics | US92790C1045 | 1.88 | 18.38 | -0.33% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 681.82B | 8.58 | 17.09 | 13.65 | ||
Fidelity Contrafund | 160.4B | 15.36 | 26.02 | 15.97 | ||
Fidelity Total Market Index Instl b | 113.87B | 8.09 | 16.45 | 12.97 | ||
Fidelity Blue Chip Growth | 67.4B | 8.98 | 26.28 | 17.99 | ||
Fidelity Growth Company | 64.44B | 9.25 | 25.04 | 18.87 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review